Commission Implementing Regulation (EU) 2017/2065 of 13 November 2017 confirming the conditions of approval of the active substance 8-hydroxyquinoline, as set out in Implementing Regulation (EU) No 540/2011 and modifying Implementing Regulation (EU) 2015/408 as regards the inclusion of the active substance 8-hydroxyquinoline in the list of candidates for substitution (Text with EEA relevance. )
Changelog
0 versionsArticle-level history is being prepared
The official source publishes these consolidated versions; article-by-article changes will appear here as soon as they are processed.
No consolidated versions are recorded for this law.